Adaptilens is a developer of an accommodating intraocular lens.
Adaptilens has raised $17.5M in total funding. The most recent round was Series A. The last funding was announced in April 2024.
Adaptilens's investors include Pillar VC, Perceptive Advisors, MassChallenge, Accanto Partners, 380 Cap.
Adaptilens is headquartered in Boston, United States.
Adaptilens is a developer of an accommodating intraocular lens.
Adaptilens is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Adaptilens — Funding & Investors." VCBacked, April 29, 2024, https://www.vcbacked.co/company/adaptilens. Accessed July 19, 2026.
VCBacked. (2024). Adaptilens — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/adaptilens
{{cite web |title=Adaptilens — Funding & Investors |url=https://www.vcbacked.co/company/adaptilens |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated